Surfactant Administration During Pediatric Extracorporeal Membrane Oxygenation

Area of Science:

• Pediatric Critical Care Medicine
• Respiratory Physiology
• Neonatology

Background:

• Surfactant administration during pediatric extracorporeal membrane oxygenation (ECMO) is not well-described.
• Its impact on clinical variables requires further investigation.

Purpose of the Study:

• To assess the effects of surfactant administration on clinical outcomes and respiratory mechanics in pediatric ECMO patients.
• To identify patient subgroups that may benefit from surfactant therapy.

Main Methods:

• Retrospective analysis of 96 pediatric ECMO courses.
• Identification of 89 surfactant administrations during 37 ECMO courses.
• Mixed-effects modeling to evaluate changes in respiratory system dynamic compliance (Cdyn).

Main Results:

• Surfactant administration was linked to respiratory indications and longer ECMO/ventilation durations.
• Hospital survival rates were similar between surfactant-treated and untreated groups (64.9% vs 72.9%).
• Dynamic compliance significantly increased within 24 hours post-surfactant, particularly in non-surgical patients.

Conclusions:

• Surfactant administration enhances respiratory system compliance in pediatric ECMO patients.
• Non-cardiac surgical patients may experience greater benefits from surfactant therapy.
• Surfactant use is associated with extended mechanical support but not increased mortality.